Small acquisition by Caroline Young of tradable shares of Cumberland Pharmaceuticals subject to Section 16

CPIX Stock  USD 2.32  0.03  1.28%   
Slightly above 62% of all Cumberland Pharmaceuticals' investors are looking to take a long position. The analysis of overall sentiment of trading Cumberland Pharmaceuticals stock suggests that some investors are interested at this time. Cumberland Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Cumberland Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Cumberland Pharmaceutical director. Exempt small acquisition under Rule 16a-6

Read at macroaxis.com
Cumberland insider trading alert for small acquisition of common stock by Caroline Young, the corporate stakeholder, on 3rd of November 2023. This event was filed by Cumberland Pharmaceutical with SEC on 2023-11-03. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Cumberland Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cumberland Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Cumberland Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Cumberland Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Cumberland Pharmaceuticals Fundamental Analysis

We analyze Cumberland Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cumberland Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cumberland Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Cumberland Pharmaceuticals is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Cumberland Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cumberland Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Cumberland Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cumberland Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Cumberland Pharmaceuticals Related Equities

PTPIPetros Pharmaceuticals   12.90   
0%
45.0%
CPHIChina Pharma   10.53   
0%
36.0%
IXHLIncannex Healthcare   8.33   
0%
29.0%
BFRIBiofrontera   3.74   
0%
13.0%
RGCRegencell Bioscience   0.61   
2.0%
0%
EVOKEvoke Pharma   0.61   
2.0%
0%
KMDAKamada   1.82   
6.0%
0%
ORGOOrganogenesis Holdings   2.74   
9.0%
0%
LFCRLifecore Biomedical   2.80   
9.0%
0%
IRWDIronwood Pharmaceuticals   3.05   
10.0%
0%
PROCProcaps Group   4.86   
17.0%
0%
AKANAkanda Corp   6.10   
21.0%
0%
SHPHShuttle Pharmaceuticals   7.50   
26.0%
0%
PRFXPainreform   28.57   
100.0%
0%

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.